Tel Aviv University Professor Itzhak Fried has completed his study of how memory neurons behave in real time. These have important implications for understanding dementia such as Alzheimer’s, and Israeli Moni Milchman developed ArchimedicX, the world’s first search engine for information about hospitals.

By: Michael Ordman

ISRAEL’S MEDICAL ACHIEVEMENTS

Watching memory at work

Tel Aviv University Professor Itzhak Fried has completed his study of how memory neurons behave in real time when they are “remembering.” He will present his findings at an upcoming Jerusalem symposium. These have important implications for understanding dementia such as Alzheimer’s.
http://www.timesofisrael.com/doh-how-homer-simpson-helps-researchers-understand-memory/

Hospital search engine wows Russia

Russia’s most dominant email service Mail.Ru is integrating the database of Archimedicx. Health Mail.Ru is one of the most popular health portals in Russia. Israeli Moni Milchman developed ArchimedicX, the world’s first search engine for information about hospitals.
http://www.geektime.com/2016/02/16/belgian-israeli-archimedicx-to-feature-its-listings-on-russian-mail-ru/

Breakthrough leukemia cure is “Israeli”

I was suspicious of the BBC’s report on the “innovative” US immunotherapy that cured 27 of 29 “no-hope” leukemia patients. Sure enough, the genetic modification of T-cells was developed by Weizmann Institute Professor Zelig Eshhar, and the US researchers accredited him.
http://www.timesofisrael.com/breakthrough-cancer-cure-has-deep-israeli-roots/#.VsSHARjfTx8.email

Positive trials for treatment of Graft vs Host disease

Israel’s Kamada has reported positive interim results from a Phase 1/2 clinical trial of its proprietary alpha-1 antitrypsin (AAT) to treat steroid-refractory Graft Versus Host Disease (GvHD). Subjects responded well to treatment in the small study.
http://www.kamada.com/news_item.php?ID=217

Patent for kidney cancer test

Israeli biotech Rosetta Genomics has been granted a US patent for its gene signature method of distinguishing four different types of kidney cancer. The molecular diagnostic test recognizes the profile of 29 microRNAs that are expressed in patients with renal cancer.
http://www.rosettagx.com/files/press_releases/2016/012516_ROSG_Kidney_Tumor_Classification_Patent_FINAL.pdf

ReWalk is medically necessary

A US surgeon, confined to a wheelchair following a spinal cord injury, has successfully won his case to be reimbursed by his health plan for a ReWalk exoskeleton. The ruling will help make ReWalk available to all eligible patients.

http://rewalk.com/rewalk-robotics-exoskeleton-deemed-medically-necessary-by-independent-medical-review-organization/

Israel-California biotech agreement

Israeli Science, Technology and Space Minister Ofir Akunis signed a biotechnology agreement with the California Institute for Regenerative Medicine (CIRM) Its focus is stem cell research and breakthroughs in treating diseases such as cancer, diabetes, Alzheimer’s and HIV-AIDS.
http://www.jns.org/news-briefs/2016/2/10/israel-and-california-sign-biotech-deal-with-emphasis-on-stem-cell-research

Click here for all of this week’s Good News from Israel.

Send Passover Packages to Needy Israeli Soldiers - Bring Them Joy!

We are honored to thank the young men and women of the IDF who risk their lives every day to protect the citizens of Israel. Since October 7th, soldiers have been on the battlefield for months - many are hoping to come home for Passover.

Join us in sending Passover food packages (and personal notes) to Israeli soldiers and their families.

Many soldiers spend the Passover holiday with needy families back home. The soldiers greatly appreciate your love and concern. Bring them Passover joy!

CLICK HERE TO SEND YOUR PACKAGE AND NOTE TO ISRAELI SOLDIERS!